Peer-influenced content. Sources you trust. No registration required. This is HCN.
GoodRx for Healthcare Professionals
The increasing incidence of young-onset colorectal cancer, comprising more than 10% of diagnoses in patients under 50, signals the need for heightened clinical awareness and prompt evaluation of suspicious symptoms regardless of age.
Family Medicine/General Practice January 21st 2025
Medical Professionals Reference (MPR)
In the BLUE-C trial, Cologuard Plus demonstrated a 93.9% sensitivity for colorectal cancer detection, significantly outperforming the 67.3% sensitivity of FIT.
Family Medicine/General Practice October 16th 2024
MDLinx
Medical errors are now recognized as the third leading cause of death in the US, emphasizing the urgent need for improved safety measures in healthcare settings.
Anesthesiology September 10th 2024
Epoch Health
Recent findings suggest extending follow-up colonoscopy intervals to 15 years for patients without a family history of colorectal cancer and with initial negative results. This could reduce unnecessary procedures without significantly increasing cancer risk.
Gastroenterology June 4th 2024
Cleveland Clinic Journal of Medicine (CCJM)
Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.
Gastroenterology April 15th 2024
In the evolving landscape of colorectal cancer screening, recent evidence suggests a critical reevaluation of the benefits and risks of routine surveillance colonoscopies in patients over 70, emphasizing the importance of individualized patient care.
Gastroenterology April 8th 2024